前收市價 | 9.43 |
開市 | 9.73 |
買盤 | 10.03 x 200 |
賣出價 | 10.13 x 100 |
今日波幅 | 9.72 - 10.19 |
52 週波幅 | 3.81 - 17.70 |
成交量 | |
平均成交量 | 292,537 |
市值 | 594.8M |
Beta 值 (5 年,每月) | 0.25 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -4.71 |
業績公佈日 | 2024年5月10日 - 2024年5月14日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 21.22 |
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IGM Biosciences (IGMS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 4.72% and 31.47%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?